Creative Medical Technology Holdings, Inc.
CELZ
Rank in Stocks
#32467
Creative Medical Technology Holdings, Inc., a biotechnology firm based in... Creative Medical Technology Holdings, Inc., a biotechnology firm based in Phoenix, Arizona, specializes in advancing adult stem cell treatments. The company's core focus spans several medical fields, including immunology, urology, orthopedics, and neurology. Among its therapeutic offerings are CaverStem, designed to address erectile dysfunction; FemCelz, which aims to restore genital sensitivity and alleviate dryness; StemSpine, developed to treat chronic lower back pain; ImmCelz, intended for stroke patients; and OvaStem, a solution for female infertility.
Share Price
$0.6121
Last synced: 2026-11-09
Market Cap
$1.58M
Change (1 day)
-1.59%
Change (1 year)
-79.53%
Country
Stock data: Financial Modeling PrepΒ·Updated Β·Not investment adviceΒ·How we calculate this
Trade Creative Medical Technology Holdings, Inc. (CELZ)
Category
Healthcare
EPS for Creative Medical Technology Holdings, Inc. (CELZ)
EPS as of September 2026 TTM: $-1.92
According to Creative Medical Technology Holdings, Inc.'s latest financial reports, its current EPS (TTM) is $-1.92. At the end of 2025 the company had an EPS of $-2.52, an increase over its 2024 EPS of $-3.71.
EPS history for Creative Medical Technology Holdings, Inc. from 2006 to 2026
EPS at the end of each year
| Year | EPS | Change |
|---|---|---|
| 2026 (TTM) | $-1.92 | -23.81% |
| 2025 | $-2.52 | -32.08% |
| 2024 | $-3.71 | -1.33% |
| 2023 | $-3.76 | -59.48% |
| 2022 | $-9.28 | -112.58% |
| 2021 | $73.75 | -111.76% |
| 2020 | $-626.88 | -87.51% |
| 2019 | $-5.02K | -55.80% |
| 2018 | $-11.35K | -34.69% |
| 2017 | $-17.38K | 217.62% |
| 2016 | $-5.47K | 326.92% |
| 2015 | $-1.28K | 9.81% |
| 2014 | $-1.17K | 2.68% |
| 2013 | $-1.14K | 6.63% |
| 2012 | $-1.07K | 6.36% |
| 2011 | $-1.00K | 39.40% |
| 2010 | $-719.00 | -45.41% |
| 2009 | $-1.32K | -39.95% |
| 2008 | $-2.19K | 451.51% |
| 2007 | $-397.67 | -795.59% |
| 2006 | $57.17 | 0.00% |
EPS for similar companies or competitors
| Company | EPS | EPS Difference | Country |
|---|---|---|---|
| $15.66 | -915.63% |
US
|
|
| $-7.07 | 268.23% |
US
|
|
| $-5.29 | 175.52% |
AU
|
|
| $12.88 | -770.84% |
BE
|
|
| $21.56 | -1,222.92% |
NL
|
Questions about Creative Medical Technology Holdings, Inc.'s earnings per share (EPS)
What is Creative Medical Technology Holdings, Inc.'s earnings per share (EPS)?
Creative Medical Technology Holdings, Inc.'s earnings per share (EPS) over the last twelve months is $-1.92, as of Sep 2026.
What was Creative Medical Technology Holdings, Inc.'s earnings per share (EPS) in 2025?
In 2025, Creative Medical Technology Holdings, Inc.'s earnings per share (EPS) was $-2.52, compared with $-3.71 in 2024.
How has Creative Medical Technology Holdings, Inc.'s earnings per share (EPS) changed since 2020?
From 2020 to 2025, Creative Medical Technology Holdings, Inc.'s earnings per share (EPS) was highest in 2021 ($73.75) and lowest in 2020 ($-626.88).
How does Creative Medical Technology Holdings, Inc.'s earnings per share (EPS) compare with similar companies?
Creative Medical Technology Holdings, Inc.'s earnings per share (EPS) ($-1.92) is higher than that of 2 of the 5 similar companies listed above. The highest among them is Argenx SE, with $21.56.